(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SET mRNA] CTD PMID:31150632 1,2-dichloroethane increases expression ISO RGD:1316680 6480464 ethylene dichloride results in increased expression of SET mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1316680 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SET mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1316680 6480464 1, 2-Dimethylhydrazine results in increased expression of SET mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1316680 6480464 Ethinyl Estradiol results in increased expression of SET mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1316680 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SET mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1316680 6480464 Ethinyl Estradiol affects the expression of SET mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1316679 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SET mRNA CTD PMID:21453500 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1316680 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1316680 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316680 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SET mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316680 6480464 Tetrachlorodibenzodioxin affects the expression of SET mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SET protein CTD PMID:16548065 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316680 6480464 Tetrachlorodibenzodioxin results in increased expression of SET mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SET mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SET mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1316679 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of SET mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1316679 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of SET mRNA CTD PMID:28628672 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of SET mRNA CTD PMID:21346803 5-aza-2'-deoxycytidine increases expression ISO RGD:1316679 6480464 Decitabine results in increased expression of SET protein CTD PMID:19294695 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1316679 6480464 [trichostatin A co-treated with Decitabine] results in increased expression of SET protein CTD PMID:19294695 5-fluorouracil decreases expression ISO RGD:1316680 6480464 Fluorouracil results in decreased expression of SET mRNA CTD PMID:19272435 aflatoxin B1 increases expression ISO RGD:1316680 6480464 Aflatoxin B1 results in increased expression of SET mRNA CTD PMID:19770486 antirheumatic drug increases expression ISO RGD:1316679 6480464 Antirheumatic Agents results in increased expression of SET mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1316680 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of SET mRNA CTD PMID:23650126 arsane increases expression ISO RGD:1316679 6480464 Arsenic results in increased expression of SET protein CTD PMID:19818359 arsenic atom increases expression ISO RGD:1316679 6480464 Arsenic results in increased expression of SET protein CTD PMID:19818359 arsenous acid increases expression ISO RGD:1316679 6480464 Arsenic Trioxide results in increased expression of SET mRNA CTD PMID:20458559 benzene affects expression ISO RGD:1316679 6480464 Benzene affects the expression of SET mRNA CTD PMID:16188086 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1316679 6480464 7 more ... CTD PMID:19150397 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1316679 6480464 Diethylhexyl Phthalate results in increased expression of SET protein CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1316680 6480464 bisphenol A results in decreased expression of SET mRNA, bisphenol A results in decreased expression of SET protein CTD PMID:22938446 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of SET protein CTD PMID:31129395 bisphenol A affects expression ISO RGD:1316679 6480464 bisphenol A affects the expression of SET mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1316679 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SET mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SET mRNA CTD PMID:30816183 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SET mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1316679 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SET mRNA CTD PMID:28628672 cadmium dichloride increases expression ISO RGD:1316679 6480464 Cadmium Chloride results in increased expression of SET mRNA CTD PMID:26472689 calcitriol decreases expression ISO RGD:1316679 6480464 Calcitriol results in decreased expression of SET mRNA CTD PMID:12798352 carbon nanotube increases expression ISO RGD:1316680 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin affects expression ISO RGD:1316679 6480464 chloropicrin affects the expression of SET mRNA CTD PMID:26352163 chromium(6+) affects expression ISO RGD:1316680 6480464 chromium hexavalent ion affects the expression of SET mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1316679 6480464 Cisplatin results in increased expression of SET protein CTD PMID:21924258 cisplatin increases response to substance ISO RGD:1316679 6480464 SET mutant form results in increased susceptibility to Cisplatin CTD PMID:24555657 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of SET mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:1316679 6480464 cobaltous chloride results in decreased expression of SET mRNA CTD PMID:19320972 copper atom increases expression ISO RGD:1316680 6480464 Copper results in increased expression of SET mRNA CTD PMID:16629173 copper(0) increases expression ISO RGD:1316680 6480464 Copper results in increased expression of SET mRNA CTD PMID:16629173 crocidolite asbestos decreases expression ISO RGD:1316680 6480464 Asbestos, Crocidolite results in decreased expression of SET mRNA CTD PMID:29279043 cyclosporin A increases expression ISO RGD:1316680 6480464 Cyclosporine results in increased expression of SET mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1316679 6480464 Cyclosporine results in decreased expression of SET mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:1316679 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of SET mRNA more ... CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1316679 6480464 Arsenic Trioxide results in increased expression of SET mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:1316680 6480464 Dibutyl Phthalate results in decreased expression of SET mRNA CTD PMID:17361019 , PMID:21266533 doxorubicin affects expression ISO RGD:1316679 6480464 Doxorubicin affects the expression of SET protein CTD PMID:29385562 elemental selenium multiple interactions ISO RGD:1316679 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA CTD PMID:19244175 enzyme inhibitor multiple interactions ISO RGD:1316679 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SET protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SET protein CTD PMID:24646710 finasteride increases expression EXP 6480464 Finasteride results in increased expression of SET mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SET mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1316680 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SET mRNA] CTD PMID:22206623 folic acid increases expression ISO RGD:1316680 6480464 Folic Acid results in increased expression of SET mRNA CTD PMID:25629700 hydrogen sulfide increases expression ISO RGD:1316680 6480464 Hydrogen Sulfide results in increased expression of SET protein CTD PMID:29932956 indometacin multiple interactions ISO RGD:1316679 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of SET mRNA more ... CTD PMID:28628672 isoprenaline decreases expression ISO RGD:1316680 6480464 Isoproterenol results in decreased expression of SET mRNA CTD PMID:20003209 lead(0) decreases expression ISO RGD:1316679 6480464 Lead results in decreased expression of SET mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:1316679 6480464 Lead results in decreased expression of SET mRNA CTD PMID:19921347 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of SET gene CTD PMID:23303685 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1316679 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SET protein CTD PMID:21692457 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SET mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of SET mRNA CTD PMID:24136188 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of SET mRNA CTD PMID:18417182 paraoxon increases expression ISO RGD:1316679 6480464 Paraoxon results in increased expression of SET mRNA CTD PMID:24413757 paraquat affects expression EXP 6480464 Paraquat affects the expression of SET mRNA CTD PMID:15206577 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SET mRNA CTD PMID:18198484 pentachlorophenol increases expression ISO RGD:1316680 6480464 Pentachlorophenol results in increased expression of SET mRNA CTD PMID:23892564 perfluorooctanoic acid decreases expression ISO RGD:1316679 6480464 perfluorooctanoic acid results in decreased expression of SET protein CTD PMID:26879310 progesterone multiple interactions ISO RGD:1316679 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SET mRNA CTD PMID:21453500 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SET mRNA CTD PMID:19013527 selenium atom multiple interactions ISO RGD:1316679 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA CTD PMID:19244175 silicon dioxide affects expression ISO RGD:1316679 6480464 Silicon Dioxide analog affects the expression of SET mRNA CTD PMID:25895662 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SET protein CTD PMID:29459688 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of SET mRNA CTD PMID:24136188 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of SET protein CTD PMID:26141394 tamoxifen affects expression ISO RGD:1316680 6480464 Tamoxifen affects the expression of SET mRNA CTD PMID:17555576 tetrachloromethane affects expression ISO RGD:1316680 6480464 Carbon Tetrachloride affects the expression of SET mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SET mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SET mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1316679 6480464 Thapsigargin results in decreased expression of SET mRNA, Thapsigargin results in decreased expression of SET protein CTD PMID:21692457 titanium dioxide decreases phosphorylation ISO RGD:1316679 6480464 titanium dioxide results in decreased phosphorylation of SET protein CTD PMID:21439344 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of SET protein CTD PMID:31129395 trichloroethene increases expression ISO RGD:1316680 6480464 Trichloroethylene results in increased expression of SET mRNA CTD PMID:19448997 trichloroethene increases expression ISO RGD:1316679 6480464 Trichloroethylene results in increased expression of SET mRNA, Trichloroethylene results in increased expression of SET protein CTD PMID:22245669 trichloroethene affects response to substance ISO RGD:1316679 6480464 SET protein affects the susceptibility to Trichloroethylene CTD PMID:22245669 trichloroethene multiple interactions ISO RGD:1316679 6480464 SET protein affects the reaction [Trichloroethylene results in increased activity of CASP3 protein] CTD PMID:22245669 trichostatin A multiple interactions ISO RGD:1316679 6480464 [trichostatin A co-treated with decitabine] results in increased expression of SET protein CTD PMID:19294695 trichostatin A increases expression ISO RGD:1316679 6480464 trichostatin A results in increased expression of SET protein CTD PMID:19294695 trimellitic anhydride increases expression ISO RGD:1316680 6480464 trimellitic anhydride results in increased expression of SET mRNA CTD PMID:19042947 valproic acid decreases expression ISO RGD:1316679 6480464 Valproic Acid results in decreased expression of SET mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:1316679 6480464 Valproic Acid affects the expression of SET mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SET mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SET mRNA CTD PMID:22615374 , PMID:23034163 vitamin E multiple interactions ISO RGD:1316679 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1316679 6480464 Vitamin E results in decreased expression of SET mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1316679 6480464 vorinostat results in decreased expression of SET protein CTD PMID:20543569
